Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2014

Open Access 01-12-2014 | Research article

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

Authors: Liseth Siemons, Peter M ten Klooster, Harald E Vonkeman, Piet LCM van Riel, Cees AW Glas, Mart AFJ van de Laar

Published in: BMC Musculoskeletal Disorders | Issue 1/2014

Login to get access

Abstract

Background

The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are two commonly used measures of inflammation in rheumatoid arthritis (RA). As current RA treatment guidelines strongly emphasize early and aggressive treatment aiming at fast remission, optimal measurement of inflammation becomes increasingly important. Dependencies with age, sex, and body mass index have been shown for both inflammatory markers, yet it remains unclear which inflammatory marker is affected least by these effects in patients with early RA.

Methods

Baseline data from 589 patients from the DREAM registry were used for analyses. Associations between the inflammatory markers and age, sex, and BMI were evaluated first using univariate linear regression analyses. Next, it was tested whether these associations were independent of a patient’s current disease activity as well as of each other using multiple linear regression analyses with backward elimination. The strengths of the associations were compared using standardized beta (β) coefficients. The multivariate analyses were repeated after 1 year.

Results

At baseline, both the ESR and CRP were univariately associated with age, sex, and BMI, although the association with BMI disappeared in multivariate analyses. ESR and CRP levels significantly increased with age (β-ESR = 0.017, p < 0.001 and β-CRP = 0.009, p = 0.006), independent of the number of tender and swollen joints, general health, and sex. For each decade of aging, ESR and CRP levels became 1.19 and 1.09 times higher, respectively. Furthermore, women demonstrated average ESR levels that were 1.22 times higher than that of men (β = 0.198, p = 0.007), whereas men had 1.20 times higher CRP levels (β = -0.182, p = 0.048). Effects were strongest on the ESR. BMI became significantly associated with both inflammatory markers after 1 year, showing higher levels with increasing weight. Age continued to be significantly associated, whereas sex remained only associated with the ESR level.

Conclusions

Age and sex are independently associated with the levels of both acute phase reactants in early RA, emphasizing the need to take these external factors into account when interpreting disease activity measures. BMI appears to become more relevant at later stages of the disease.
Literature
1.
go back to reference Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, et al: American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011, 63: 573-586. 10.1002/art.30129.CrossRefPubMedPubMedCentral Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, et al: American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011, 63: 573-586. 10.1002/art.30129.CrossRefPubMedPubMedCentral
2.
go back to reference Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Wildmark R, Williams J, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum. 1993, 36: 729-740. 10.1002/art.1780360601.CrossRefPubMed Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Wildmark R, Williams J, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum. 1993, 36: 729-740. 10.1002/art.1780360601.CrossRefPubMed
3.
go back to reference Prevoo ML, van’ t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002/art.1780380107.CrossRefPubMed Prevoo ML, van’ t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002/art.1780380107.CrossRefPubMed
4.
go back to reference Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS: Kelly’s Textbook of Rheumatology. 2009, Philadelphia: Saunders Elsevier Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS: Kelly’s Textbook of Rheumatology. 2009, Philadelphia: Saunders Elsevier
5.
go back to reference Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010, 69: 631-637. 10.1136/ard.2009.123919.CrossRefPubMedPubMedCentral Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010, 69: 631-637. 10.1136/ard.2009.123919.CrossRefPubMedPubMedCentral
6.
go back to reference Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H: EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007, 66: 34-45.CrossRefPubMed Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H: EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007, 66: 34-45.CrossRefPubMed
7.
go back to reference Turkiewicz AM, Moreland LW: Rheumatoid arthritis. Clinical Care in the Rheumatic Diseases. Edited by: Bartlett SJ. 2006, Atlanta (GA): Association of Rheumatology Health Professionals, 157-166. Turkiewicz AM, Moreland LW: Rheumatoid arthritis. Clinical Care in the Rheumatic Diseases. Edited by: Bartlett SJ. 2006, Atlanta (GA): Association of Rheumatology Health Professionals, 157-166.
8.
go back to reference Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet. 2001, 358: 903-911. 10.1016/S0140-6736(01)06075-5.CrossRefPubMed Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet. 2001, 358: 903-911. 10.1016/S0140-6736(01)06075-5.CrossRefPubMed
9.
go back to reference Kushner I: C-reactive protein in rheumatology. Arthritis Rheum. 1991, 34: 1065-1068. 10.1002/art.1780340819.CrossRefPubMed Kushner I: C-reactive protein in rheumatology. Arthritis Rheum. 1991, 34: 1065-1068. 10.1002/art.1780340819.CrossRefPubMed
10.
11.
go back to reference Miller A, Green M, Robinson D: Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983, 286: 266-CrossRef Miller A, Green M, Robinson D: Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983, 286: 266-CrossRef
12.
go back to reference Shearn MA, Kang IY: Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol. 1986, 13: 297-298.PubMed Shearn MA, Kang IY: Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol. 1986, 13: 297-298.PubMed
13.
go back to reference De Silva DA, Woon FP, Chen C, Chang HM, Wong MC: Serum erythrocyte sedimentation rate is higher among ethnic South Asian compared to ethnic Chinese ischemic stroke patients. Is this attributable to metabolic syndrome or central obesity?. J Neurol Sci. 2009, 276: 126-129. 10.1016/j.jns.2008.09.015.CrossRefPubMed De Silva DA, Woon FP, Chen C, Chang HM, Wong MC: Serum erythrocyte sedimentation rate is higher among ethnic South Asian compared to ethnic Chinese ischemic stroke patients. Is this attributable to metabolic syndrome or central obesity?. J Neurol Sci. 2009, 276: 126-129. 10.1016/j.jns.2008.09.015.CrossRefPubMed
14.
go back to reference Böttiger LE, Svedberg CA: Normal erythrocyte sedimentation rate and age. Br Med J. 1967, 2: 85-87.CrossRefPubMed Böttiger LE, Svedberg CA: Normal erythrocyte sedimentation rate and age. Br Med J. 1967, 2: 85-87.CrossRefPubMed
15.
go back to reference Radovits BJ, Fransen J, van Riel PL, Laan RF: Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 1127-1131. 10.1136/ard.2007.079913.CrossRefPubMed Radovits BJ, Fransen J, van Riel PL, Laan RF: Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 1127-1131. 10.1136/ard.2007.079913.CrossRefPubMed
16.
go back to reference Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE: Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005, 32: 1040-1042.PubMed Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE: Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005, 32: 1040-1042.PubMed
17.
go back to reference Hayes GS, Stinson IN: Erythrocyte sedimentation rate and age. Arch Ophthalmol. 1976, 94: 939-940. 10.1001/archopht.1976.03910030473007.CrossRefPubMed Hayes GS, Stinson IN: Erythrocyte sedimentation rate and age. Arch Ophthalmol. 1976, 94: 939-940. 10.1001/archopht.1976.03910030473007.CrossRefPubMed
18.
go back to reference Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM: Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum. 2005, 52: 3651-3659. 10.1002/art.21400.CrossRefPubMed Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM: Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum. 2005, 52: 3651-3659. 10.1002/art.21400.CrossRefPubMed
19.
go back to reference Fransen J, Welsing PMJ, de Keijzer RMH, van Riel PLCM: Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis. 2003, 62: 151-10.1136/ard.62.2.151.CrossRef Fransen J, Welsing PMJ, de Keijzer RMH, van Riel PLCM: Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis. 2003, 62: 151-10.1136/ard.62.2.151.CrossRef
20.
go back to reference Crowson CS, Rahman MU, Matteson EL: Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol. 2009, 36: 1606-1610. 10.3899/jrheum.081188.CrossRefPubMed Crowson CS, Rahman MU, Matteson EL: Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol. 2009, 36: 1606-1610. 10.3899/jrheum.081188.CrossRefPubMed
21.
go back to reference Kawamoto R, Kusunoki T, Abe M, Kohara K, Miki T: An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons. Ann Clin Biochem. 2013, 50: 457-464. 10.1177/0004563212473445.CrossRefPubMed Kawamoto R, Kusunoki T, Abe M, Kohara K, Miki T: An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons. Ann Clin Biochem. 2013, 50: 457-464. 10.1177/0004563212473445.CrossRefPubMed
22.
go back to reference Piéroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C: Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab. 2003, 29: 133-138. 10.1016/S1262-3636(07)70019-8.CrossRefPubMed Piéroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C: Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab. 2003, 29: 133-138. 10.1016/S1262-3636(07)70019-8.CrossRefPubMed
23.
go back to reference Lee YJ, Lee JH, Shin YH, Kim JK, Lee HR, Lee DC: Gender difference and determinants of C-reactive protein level in Korean adults. Clin Chem Lab Med. 2009, 47: 863-869.PubMed Lee YJ, Lee JH, Shin YH, Kim JK, Lee HR, Lee DC: Gender difference and determinants of C-reactive protein level in Korean adults. Clin Chem Lab Med. 2009, 47: 863-869.PubMed
24.
go back to reference Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Herrington DM: Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006, 152: 593-598. 10.1016/j.ahj.2006.02.015.CrossRefPubMed Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Herrington DM: Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006, 152: 593-598. 10.1016/j.ahj.2006.02.015.CrossRefPubMed
25.
go back to reference Rommel J, Simpson R, Mounsey JP, Chung E, Schwartz J, Pursell I, Gehi A: Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am J Cardiol. 2013, 111: 208-212. 10.1016/j.amjcard.2012.09.017.CrossRefPubMed Rommel J, Simpson R, Mounsey JP, Chung E, Schwartz J, Pursell I, Gehi A: Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am J Cardiol. 2013, 111: 208-212. 10.1016/j.amjcard.2012.09.017.CrossRefPubMed
26.
go back to reference Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK: Associations between body mass index and serum levels of C-reactive protein. S Afr Med J. 2009, 99: 326-330.PubMed Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK: Associations between body mass index and serum levels of C-reactive protein. S Afr Med J. 2009, 99: 326-330.PubMed
27.
go back to reference Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS: Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 2003, 35: 1160-1166. 10.1249/01.MSS.0000074565.79230.AB.CrossRefPubMed Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS: Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 2003, 35: 1160-1166. 10.1249/01.MSS.0000074565.79230.AB.CrossRefPubMed
28.
go back to reference Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA: Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch rheumatoid arthritis monitoring remission induction cohort study. Arthritis Rheum. 2011, 63: 2865-2872. 10.1002/art.30494.CrossRefPubMed Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA: Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch rheumatoid arthritis monitoring remission induction cohort study. Arthritis Rheum. 2011, 63: 2865-2872. 10.1002/art.30494.CrossRefPubMed
29.
go back to reference Siemons L, ten Klooster PM, Vonkeman HE, Glas CAW, van de Laar MAFJ: Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res. 2014, 66: 625-630. 10.1002/acr.22175.CrossRef Siemons L, ten Klooster PM, Vonkeman HE, Glas CAW, van de Laar MAFJ: Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res. 2014, 66: 625-630. 10.1002/acr.22175.CrossRef
30.
go back to reference Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum. 1980, 23: 137-145. 10.1002/art.1780230202.CrossRefPubMed Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum. 1980, 23: 137-145. 10.1002/art.1780230202.CrossRefPubMed
31.
go back to reference Ware JE, Kosinski M, Dewey JE: How to Score Version Two of the SF-36 Health Survey. 2000, Lincoln, RI: QualityMetric, Incorporated Ware JE, Kosinski M, Dewey JE: How to Score Version Two of the SF-36 Health Survey. 2000, Lincoln, RI: QualityMetric, Incorporated
32.
go back to reference Albert MA, Glynn RJ, Ridker PM: Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004, 93: 221-225. 10.1016/j.amjcard.2003.09.046.CrossRefPubMed Albert MA, Glynn RJ, Ridker PM: Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004, 93: 221-225. 10.1016/j.amjcard.2003.09.046.CrossRefPubMed
33.
go back to reference Husain TM, Kim DH: C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J. 2002, 15: 13-16. Husain TM, Kim DH: C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J. 2002, 15: 13-16.
34.
go back to reference Vermeer M, Kievit W, Kuper HH, Braakman-Jansen LM, Bernelot Moens HJ, Zijlstra TR, den Broeder AA, van Riel PL, Fransen J, van de Laar MA: Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet Disord. 2013, 14: 350-10.1186/1471-2474-14-350.CrossRefPubMedPubMedCentral Vermeer M, Kievit W, Kuper HH, Braakman-Jansen LM, Bernelot Moens HJ, Zijlstra TR, den Broeder AA, van Riel PL, Fransen J, van de Laar MA: Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet Disord. 2013, 14: 350-10.1186/1471-2474-14-350.CrossRefPubMedPubMedCentral
35.
go back to reference Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, Williams P, Winfield J: How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000, 39: 603-611. 10.1093/rheumatology/39.6.603.CrossRef Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, Williams P, Winfield J: How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000, 39: 603-611. 10.1093/rheumatology/39.6.603.CrossRef
36.
go back to reference Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van’t Hof MA, Schreuder FH, Leirisalo-Repo M, van Riel PL: Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 453-458. 10.1136/ard.60.5.453.CrossRefPubMedPubMedCentral Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van’t Hof MA, Schreuder FH, Leirisalo-Repo M, van Riel PL: Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 453-458. 10.1136/ard.60.5.453.CrossRefPubMedPubMedCentral
Metadata
Title
How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis
Authors
Liseth Siemons
Peter M ten Klooster
Harald E Vonkeman
Piet LCM van Riel
Cees AW Glas
Mart AFJ van de Laar
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2014
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-15-368

Other articles of this Issue 1/2014

BMC Musculoskeletal Disorders 1/2014 Go to the issue